Healthcare · Medical - Diagnostics & Research
Price
$0.83
Market Cap
$3.8M
Employees
57
Beta
-1.34
Avg Volume
970,075
CEO
Maria Zannes
Business Description
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
Business History
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
-0.10
Stock Price: $0.83
EPS (Diluted): -8.66
EPS (Diluted): -8.66
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
0.28
Stock Price: $0.83
Total Equity: $7.28M
Shares: 1,721,082
Total Equity: $7.28M
Shares: 1,721,082
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
0.23
Market Cap: $3.76M
Total Debt: $425,184
Cash: $6.45M
EBITDA: -$14.32M
Total Debt: $425,184
Cash: $6.45M
EBITDA: -$14.32M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
-$3.3M
Market Cap: $3.76M
Total Debt: $425,184
Cash: $6.45M
Total Debt: $425,184
Cash: $6.45M
P/S Ratio (Price per dollar of revenue)
APIStock Price / Revenue Per Share
0.33
Stock Price: $0.83
Revenue: $6.16M
Shares: 1,721,082
Revenue: $6.16M
Shares: 1,721,082
EV/Sales (Total value vs revenue — works when P/E can't)
API-0.53
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
23.2%
Gross Profit: $1.43M
Revenue: $6.16M
Revenue: $6.16M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
-171.6%
Operating Income: -$10.57M
Revenue: $6.16M
Revenue: $6.16M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
-242.0%
Net Income: -$14.91M
Revenue: $6.16M
Revenue: $6.16M
ROE (Profit from shareholder equity)
CALCNet Income / Total Equity
-204.9%
Net Income: -$14.91M
Total Equity: $7.28M
Total Equity: $7.28M
ROIC (Profit from all invested capital)
CALCNOPAT / Invested Capital
-846.2%
Operating Income: -$10.57M
Tax Rate: -0.3%
Equity: $7.28M
Total Debt: $425,184
Cash: $6.45M
Tax Rate: -0.3%
Equity: $7.28M
Total Debt: $425,184
Cash: $6.45M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
2.60
Current Assets: $7.57M
Current Liabilities: $2.91M
Current Liabilities: $2.91M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
0.06
Short-Term Debt: $383,871
Long-Term Debt: $41,313
Total Debt: $425,184
Total Equity: $7.28M
Long-Term Debt: $41,313
Total Debt: $425,184
Total Equity: $7.28M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$3.58
Revenue: $6.16M
Shares: 1,721,082
Shares: 1,721,082
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$4.23
Total Equity: $7.28M
Shares: 1,721,082
Shares: 1,721,082
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$-5.46
Operating CF: -$9.33M
CapEx: -$60,568
Shares: 1,721,082
CapEx: -$60,568
Shares: 1,721,082
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.83
Stock Price: $0.83
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$14.91M
Net Income: -$14.91M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares BIAF against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 20, 2026 11:43am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $4,803 | $2.5M | $9.4M | $6.2M |
| Cost of Revenue | $4,817 | $467 | $1.7M | $6.0M | $4.7M |
| Gross Profit | $-4,817 | $4,336 | $791,615 | $3.4M | $1.4M |
| Operating Expenses | $2.2M | $4.0M | $8.8M | $12.3M | $12.0M |
| Operating Income | -$2.2M | -$4.0M | -$8.0M | -$9.0M | -$10.6M |
| Net Income | -$6.3M | -$8.2M | -$7.9M | -$9.0M | -$14.9M |
| EBITDA | -$5.3M | -$5.6M | -$7.6M | -$8.3M | -$14.3M |
| EPS | $-70.86 | $-54.30 | $-27.30 | $-22.50 | $-8.66 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 20, 2026 11:43am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.4M | $11.4M | $2.8M | $1.1M | $6.4M |
| Total Current Assets | $1.4M | $12.0M | $4.0M | $2.7M | $7.6M |
| Total Assets | $1.5M | $12.2M | $8.2M | $6.5M | $11.0M |
| Current Liabilities | $13.0M | $1.1M | $2.2M | $3.1M | $2.9M |
| Long-Term Debt | $160,184 | $0 | $0 | $20,180 | $41,313 |
| Total Liabilities | $17.2M | $1.1M | $3.4M | $3.9M | $3.7M |
| Total Equity | -$15.8M | $11.0M | $4.9M | $2.6M | $7.3M |
| Retained Earnings | -$28.5M | -$36.7M | -$44.6M | -$53.6M | -$68.6M |
Cash Flow (Annual)
Last updated: Jun 20, 2026 11:43am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$2.0M | -$4.1M | -$6.0M | -$7.3M | -$9.3M |
| Capital Expenditure | $-2 | $-219,987 | $-22,902 | $-79,083 | $-60,568 |
| Free Cash Flow | -$2.0M | -$4.3M | -$6.1M | -$7.3M | -$9.4M |
| Acquisitions (net) | $0 | $0 | -$2.2M | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $1.3M | $10.1M | -$8.6M | -$1.7M | $5.3M |
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 1:08am (9h ago)| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue |
$2.1M $2.1M – $2.1M
|
$9.6M $9.6M – $9.6M
|
$6.1M $6.1M – $6.1M
|
$7.3M $7.3M – $7.3M
|
| EBITDA |
$-373,702 $-373,702 – $-373,702
|
-$5.5M -$5.5M – -$5.5M
|
-$3.5M -$3.5M – -$3.5M
|
-$4.2M -$4.2M – -$4.2M
|
| Net Income |
-$10.2M -$10.2M – -$10.2M
|
-$35.6M -$35.6M – -$35.6M
|
-$24.8M -$24.8M – -$24.8M
|
-$13.9M -$13.9M – -$13.9M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 20, 2026 11:43am (6d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | — | +52,617.1% | +269.7% | -34.2% |
| Gross Profit Growth | +190.0% | +18,156.8% | +326.8% | -57.7% |
| Operating Income Growth | -81.8% | -98.8% | -12.3% | -18.1% |
| Net Income Growth | -28.9% | +2.7% | -13.9% | -64.9% |
| EBITDA Growth | -5.5% | -36.0% | -9.2% | -71.9% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for BIAF — it's generated by the pipeline (
market-narrative step).
No community reviews yet for BIAF.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30